Treating opioid dependence with extended-release naltrexone (XR-NTX) in Ukraine: Feasibility and three-month outcomes

Authors:

Abstract
No abstract available
Funding Information
  • National Institute on Drug Abuse (R01 DA029910, K24 DA017072, R01 DA033679)
  • Fogarty International Center (D43TW000233)
  • National Institute of Allergy and Infectious Diseases (R25 TW009338)

This publication has 56 references indexed in Scilit: